Диссертация (1139649), страница 48
Текст из файла (страница 48)
[Accessed 23 March 2011]. Available from:http://www.bcgatlas.org/index.php.152.BCG vaccination and TB in children. Autors’ reply to Turner andcolleagues / I. Abubakar, S. Sridhar, M. Eisenhut [et al.] // Brit. Med. J. – 2014. Vol. 349. – P. 1756 – 1833.153.BCG vaccination and tuberculosis in Japan / M. Rahmn, O.
Takahashi, M.Goto, T. Fukui // J. Epidemiol. – 2003. - Vol. 13, N 3. – P. 127 - 135.154.BCG vaccination by bifurcated needle in a pilot vaccination programme /A. Dermanger, S. Nekzad, M. Kuis [et al.] // Bull. World Health Organ. – 1977. –Vol. 55. – P. 49 - 59.155.BCG Vaccine: Safety / World Health Organ. - Geneva, 2014. -http://www.who.int/vaccine_safety/committee/topics/bcg/en/156.BCG vaccine.
WHO position paper / World Health Organ. // WklyEpidemiol. Rec. – 2004. – Vol. 79. – P. 27–38.157.BCGVaccines.WorldHealthOrgan.-Geneva,2014-http://www.who.int/biologicals/areas/vaccines/en/.158.Bellet, J.S. Skin complications of Bacillus Calmette-Guérin immunization /300J.S. Bellet, N.S. Prose // Current Opin. Infect. Dis. – 2005. – Vol.
18, N 2. – P.97–100.159.Blasi, F. Presenting the European Forum for TB Innovation: innovativethinking in progressing towards TB elimination in Europe / F. Blasi, L.B.Reichman, G.B. Migliori // Eur. Resp. J. – 2012. – Vol. 40. – P. 806–808.160.Bloom, B. New approuches to vaccine development / B. Bloom // Rev.Infect. Dis. – 1989. – Vol.
11 - P. 460 - 466.161.Bloom, B.R. The evolving relation between humans and Mycobacteriumtuberculosis / B.R. Bloom, P.M. Small // N. Engl. J. Med. – 1998. - Vol. 338. - P.677 - 678.162.Brannan, M.J. Tuberculosis Vaccines: A Strategic Blueprint for the NextDecade / M.J. Brennan, J. Thole // Tuberculosis (Edimb). – 2012. - Vol 92, Suppl1. - S. 6 – 13.163.Brodin P., Majlessi L., Brosh R., et al. // Enhanced protection againsttuberculosis by vaccination with recombinant Micobacterium microtti vaccine thatinduces T cell immunity against region of difference 1 antigens.
The Journal ofInfectious Diseases.- 2004.- P. 115-122.164.Breung, B. BCG-impfung und Kindertuberkulose lose / B. Breung // Mitt.ost. Sanit. - 1989. - Bd. 90, № 5. - P. 182 - 184.165.Brewer, T.F. Relationship between Bacille Calmette-Guerin strains and theefficacy of BCG vaccine in the prevention of tuberculosis / T.F. Brewer, G.A.Colditz // Clin. Infect. Dis. – 1995.
– Vol. 20. – P. 126 -135.166.Bruton, O.C. Agammaglobulinemia / O.C. Bruton // Pediatrics. – 1952.Vol. 9. – P. 722 - 728.167.Bunch-Christensen, K. The virulence of some strains of BCG for goldenhamsters. Further studies / K. Bunch-Christensen, A. Ladefoged, J. Guld // Bull.World Health Organ. – 1970. – Vol. 43, N 1.
– P. 65–67.168.Calmette, A.La Vaccination Preventive contra la Tuberculosis / A.Calmette. - Paris: Masson et. Cie, 1927. – 250 p.169.Casanova, J.L. Genetic dissection of immunity to Mycobacteria: The301human model / J.L. Casanowa, L. Abel // Annu Rev. Immunol. – 2002. - Vol. 20.- P. 581 - 620.170.Casanova, J.L. Mendelain Susceptibility to mycobacterial infection in man/ J.L. Casanova // Swiss Med. Wkly. – 2001. Vol.
131. - P. 445 - 454.171.Case-control study on evalution of BCG vaccination of newborn inRangoon / T. Muint, H. Win, H. Aye [et al.] // Ann. Trop. Paediatr. – 1987. –Vol.7. – P. 159 - 166.172.Castro-Rodriguez, J.A. Osteitis caused by bacille Calmette-Guerinvaccination: an emergent problem in Chile? / J.A. Castro-Rodriguez, R. Gonzalez,G.
Girardi // Int. J. Tuberc. Lung Dis. – 1997. - Vol. 1, N 5. – P. 417 - 421.173.Child's tuberculous lymphadenitis with fistula evoked by the BCG stem / J.Jakubikova, J. Trupl, E. Neviska [et al.] // Int. J. Pediatr. Otorhinilarygol. - 1996. Vol. 37, № 1. - P. 85 - 90.174.Cerda de Palou, E. Lymphadenitis as a complication following vaccinationwith Bacillus Calmette-Guerin (BCG) / E. Cerda de Palou, H.P. de Santy // Ned.Tijdschr. Geneeskd. – 2003. – Vol.
147, N 12. – P. 569 - 572.175.Characterisation of complex chromosome 18p rearragements in twosyndromic pacients with immunological deficits / M.P. Recalsati, E. Valtorta, L.Romitti [et al.] // Eur. J. Med. Genet. – 2010. – Vol. 11. – P. 111 - 117.176.Chouchkova, M. Centenary of the BCG vaccine / M. Chouchkova, T.Stefanova, A. Mihaylov // Annual congress of the European society ofmycobacteriology, 29-th: abstr. book. – Plobdiv (Bulgaria), 2008. P. 5 – 9.177.Clemens, J. The BCG controversy. A methodological and statisticalreappraisal / J. Clemens, J. Chuong, A. Feinstein // J.
Amer. Med. Assoc. - 1983. –Vol. 249. - P. 2362 - 2369.178.Clinical presentations of Calmette-Guerin infections in patients withimmunodeficiency syndromes / B. Gonsales, S. Moreno, R. Burdach [et al.] //Pediatr. Infect. Dos. J. – 1989. - Vol. 8. - P. 201 - 206.179.Clinical spectrum of X-linked hyper IgM syndrome / J. Levy, T. Expanol-Boren, C. Thomas [et al.] // J. Pediatr.
– 1997. - Vol. 131. - P. 47-54.302180.Global tuberculosis report 2014. World Health Organization Availableat:http://www.who.int/tb/publications/global_report/en.181.Comparative trial of administration of half (0.05 mg) and quarter (0.025mg) dose of intradermal Pasteur BCG on 291 infants from birth to 1 year inFrench Guyana / L. Teulieres, M.A.
Diouf, P. Chaud [et al.] // Vaccine. -1991. Vol. 9, N 7. – P. 521 - 524.182.Comparison of immune responses of mice immunized with five differentMicobacterium bovis BCG vaccine strains / M.R.R. Lagranderie, A.M. Balazuc,E. Deriaud [et al.] // Infect. Immun. – 1996. – Vol. 64, N 1. – P. 1 - 9.183.Consensus statement Global burden of tuberculosis: estimated incidence,prevalence, and mortality by country. WHO Global Surveillance and MonitoringProject / C. Dye, S. Scheele, P. Dolin [et al.] // J. Amer.
Med. Assoc. – 1999. –Vol. 282. – P. 677– 686.184.ConsensusstatementontherevisedWorldHealthOrganizationrecommendations for BCG vaccination in HIV-infected infants / A. C. Hesseling[et al.]: Submitted on behalf of the BCG Working Group, Child Lung HealthSection, Inter national Union Against Tuberculosis and Lung Disease, 38th UnionWorld Conference on Lung Health, Cape Town, 8–12 November, 2007 // Int. J.Tuberc.
Lung. Dis. - 2008. – Vol. 12. – P. 1376–1379.185.S.Contraindicated BCG vaccination of “at risk” infants / P. Rees, H. Evans,Pnesar[etal]//Brit.Med.J.-http://www.bmj.com/content/349/bmj.g4643/rr/762808.186.Criteria for discontinuation of vaccination programmes using BacilleCalmette-Guerin (BCG) in countries with a low prevalence of tuberculosis: Astatement of the IUATLD // Tubercle.
- 1994. - Vol. 75, № 3. - P. 179 - 180.187.Delaying BCG vaccination from birth to 10 weeks of age may result in anenhanced memory CD4 T cell response / M.N. Benjamin, A. Brian, M.Bowmaker[et al.] // Vaccine. – 2009. – Vol. 27, N 40. – P. 5488–5495.188.Development of the Mycobacterium bovis BCG vaccine: review of thehistorical and biochemical evidence for a genealogical tree / T. Oettinger, M.303Jorgensen, A. Ladefogel [et al.] // Tuber. Lung Dis. – 1999.
– Vol. 79. – P. 243–250.189.Deweerdt, C. Vaccines: the age-old problem / C. Deweerdt // Nature. -2013. – Vol. 10, N 502(7470). - S. 8 - 9.190.Disseminated bacilli Calmette-Guerin disease after vaccination: case reportand review / E.A. Talbot, M.D. Perkins, S.F. Silva, R.
Frothingham // Clin. Infect.Dis. – 1997, Vol. 24. – P. 1139 - 1146.191.Disseminated bacille Calmette-Guerin disease in HIV-infected SouthAfrican infants / A.C. Hesseling, L.F. Johnson, H. Jaspan // Bull. World HealthOrgan. – 2009. – Vol. 87. – P. 505–511.192.Disseminated bacille Calmette-Guerin infection in an infant with a noveldeletion in the interferon-gamma receptor gene / J.A. Cunningham, J.D.
Kellner,P.J. Bridge [et al.] // Int. J. Tuberc. Lung Dis. – 2000. - Vol. 4, N 8. – P. 791 - 794.193.Dorman, S.E. Interferon-gamma and interleukin-12 pathway defects andhuman disease / S.E. Dorman, S.M. Holland // Cytokine Growth Factor Rev. 2000. - Vol. 11. - P. 321 - 333.194.Epidemiological and clinical study of tuberculosis in the district of Kolin,Czechoslovakia. Report for the first 4 years of the study (1961–64) / K.
Styblo, D.Dankova, J. Drapela [et al.] // Bull. World Health Organ. – 1967. – Vol. 37. – P.819–874.195.Effect of BCG revaccination on incidence of tuberculosis in school-agedchildren in Brazil: the BCG-REVAC cluster-randomised trial / L.C. Rodrigues,S.M. Pereira, S.S. Cunha [et al.] // Lancet. – 2005. – Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
